Joshua Thornsberry's Avatar

Joshua Thornsberry

@thornsberryjd.bsky.social

πŸŽ“ DNP πŸ₯Ό Nurse Practitioner πŸ«€ Hearts πŸ₯ APP Fellowship Director 🍎 Educator 🏠 ATL πŸ³οΈβ€πŸŒˆ LGBTQ+ ⛺️ Camper #ACC #ACCCVT #CCKE #ACCPRIDE #AANP #NPsLead #CardioSky #MedSky DNP, AGACNP-BC, ANP-BC, CCK, AACC

201 Followers  |  420 Following  |  36 Posts  |  Joined: 16.11.2024  |  2.1291

Latest posts by thornsberryjd.bsky.social on Bluesky

Post image

An interesting study looking at using a deep learning model to evaluate ECGs in the emergency room to determine if patients need coronary revascularization as existing methods can sometimes be inconclusive.
academic.oup.com/eurheartj/ad...

05.04.2025 12:53 β€” πŸ‘ 3    πŸ” 3    πŸ’¬ 1    πŸ“Œ 0
Post image

Tomorrow is your last chance to visit this BP measurement learning station at #ACC25!

Avoiding common pitfalls is key to accurate careβ€”don’t miss it in the Personalized Skills Center.

learn.acc.org/Page/LEARNHTN

#ACCCVT #CardioSky #WellstarCVteam

@accintouch.bsky.social @jaccjournals.bsky.social

30.03.2025 22:11 β€” πŸ‘ 3    πŸ” 3    πŸ’¬ 0    πŸ“Œ 1
Post image

ALPACA: The novel extended-duration small interfering RNA lepodisiran reduced mean serum concentrations of Lp(a) from 60 to 180 days after being administered subcutaneously. #ACC25

Learn more about the study ➑️ bit.ly/3Y1DkU7

#CardioSky #MedSky

30.03.2025 20:25 β€” πŸ‘ 12    πŸ” 5    πŸ’¬ 0    πŸ“Œ 1
Post image Post image Post image Post image

Dr. Victor Dzau presenting his keynote speech, Science, Medicine, and Society: A Brave New World, during the 2025 Eugene Braunwald Keynote happening now! πŸ“Room S100b

#ACC25 #CardioSky

30.03.2025 20:40 β€” πŸ‘ 5    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0
Post image

FRESH-UP Trial #ACC25 #medsky

RCT comparing liberal vs restricted fluid intake (≀1500 ml/d) in 504 pts with stable chronic HF

🌊No difference in status health quantified by Kansas City Cardiomyopathy Questionnaire at 3 mths
🌊 More thirst distress with restriction

www.nature.com/articles/s41...

30.03.2025 20:50 β€” πŸ‘ 24    πŸ” 15    πŸ’¬ 0    πŸ“Œ 2
Post image Post image Post image

Dr. Victor Dzau:
How do we improve #cvd with rising #obesity?
βœ…Start with 1Β° and 2Β° #cvprev
βœ…Primordial prevention

@accintouch.bsky.social #acc25

30.03.2025 21:11 β€” πŸ‘ 5    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0
Post image

Dr. Victor Dzau:
Future of #CVD care is going to be evolving rapidly over the next century:
❀️ Emphasis on prevention
❀️ Equitable access and affordable
❀️ Mission-based innovation
❀️ Develop national priorities

Need governance to oversee innovation, ensure ethics

#acc25
@accintouch.bsky.social

30.03.2025 21:24 β€” πŸ‘ 6    πŸ” 4    πŸ’¬ 0    πŸ“Œ 0

A multidisciplinary approachβ€”from cardiology to nursing to pharmacyβ€”shows what’s possible when we work together.

The result? A jump in SGLT2i prescribing rates and more holistic post-AMI care!

#ACC25 #CardioSky #WellstarCVteam #ACCCVT

@accintouch.bsky.social @jaccjournals.bsky.social

30.03.2025 21:44 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Wellstar team-based care in action at #ACC25!

This poster showcases a coordinated strategy to improve SGLT2i use post-AMIβ€”driving better prescribing, education, and follow-up for patients.

#ACCCVT #CardioSky #WellstarCVteam

@accintouch.bsky.social @jaccjournals.bsky.social

30.03.2025 21:44 β€” πŸ‘ 3    πŸ” 2    πŸ’¬ 1    πŸ“Œ 0

These findings will reshape how care teams educate and manage patients with HFβ€”allowing us to shift focus from fluid limits to the underlying drivers of decompensation that truly impact outcomes.

@accintouch.bsky.social @jaccjournals.bsky.social

#ACC25 #WellstarCVteam #ACCCVT

30.03.2025 21:36 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

FRESH-UP at #ACC25: No benefit to fluid restriction in HF. No harm with liberal intake. Improved QOL with more fluid freedom.

Supports what we have long suspectedβ€”and may help shift the standard of care moving forward.

#CardioSky #WellstarCVteam

@accintouch.bsky.social @jaccjournals.bsky.social

30.03.2025 21:36 β€” πŸ‘ 3    πŸ” 3    πŸ’¬ 1    πŸ“Œ 0
Post image

#ACC25 #LGBTQ work group represents at the Health #Equity Hub!

Dr Deb and Dr Coylewright - So proud of the work you’re both doing!

@thornsberryjd.bsky.social
@brototod.bsky.social

30.03.2025 16:37 β€” πŸ‘ 5    πŸ” 1    πŸ’¬ 0    πŸ“Œ 1
Post image

Join us for this exciting session on management of CIEDs in complex patients -
#ACC25 #CIED #cardiopalli #SDM
@accintouch.bsky.social @thornsberryjd.bsky.social

30.03.2025 18:19 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

EquiOx at #ACC25 confirms it: pulse oximeters don’t perform equally across skin tonesβ€”especially critically ill patients

Wellstar’s, Dr. Paul Douglass shared insight on the need for equity in device validation

#ACCCVT #CardioSky #WellstarCVteam

@accintouch.bsky.social @jaccjournals.bsky.social

30.03.2025 15:16 β€” πŸ‘ 6    πŸ” 5    πŸ’¬ 0    πŸ“Œ 0
Post image

MIGHTy-Heart took on gaps in HF care transitions.

✴️ 2,003 enrolled β†’ MIH vs. TOCC
✴️ No difference in 30-day outcomes
✴️ Younger patients & women saw more benefit.

Impressive representation: 52% women, 47% Black

#ACC25 #CardioSky #WellstarCVteam

@accintouch.bsky.social @jaccjournals.bsky.social

30.03.2025 15:12 β€” πŸ‘ 2    πŸ” 4    πŸ’¬ 0    πŸ“Œ 0

πŸ”₯Hot off the press:

Highlights from day 1 at #ACC25 #CardioSky

πŸ“Œ WARRIOR
πŸ“Œ STRIDE
πŸ“Œ API-CAT
πŸ“Œ SOUL
πŸ“Œ RIVAWAR
πŸ“Œ & more in the link

www.healio.com/news/cardiol...

30.03.2025 00:08 β€” πŸ‘ 2    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0
Preview
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes | NEJM The cardiovascular safety of oral semaglutide, a glucagon-like peptide 1 receptor agonist, has been established in persons with type 2 diabetes and high cardiovascular risk. An assessment of the ca...

Among persons with type 2 diabetes and atherosclerotic cardiovascular disease, chronic kidney disease, or both, oral semaglutide was associated with a significantly lower risk of major adverse cardiovascular events than placebo #MedSky #CardioSky #NephSky
www.nejm.org/doi/full/10....

30.03.2025 00:09 β€” πŸ‘ 4    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Preview
Intensive medical therapy does not help or harm women with chest pain: WARRIOR CHICAGO — Among women with suspected ischemia with nonobstructive coronary disease, an intensive medical therapy strategy did not reduce risk for major adverse CV events at 5 years compared with...

More from day 1 #ACC25 …

πŸ“Œ WARRIOR = the largest study of women with suspected ischemia with nonobstructive coronary disease

πŸ“Œ Intensive medical therapy did not prevent πŸ«€ events for women with INOCA

πŸ“Œ β€œThis trial should not be considered a negative trial”

www.healio.com/news/cardiol...

30.03.2025 00:12 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

You folks lead with compassion! Such important work!

29.03.2025 23:30 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0
Post image Post image

#ACC25 #Palliative Workgroup Huddle!

So much creativity and compassion - and WORK - in the this group!

#ACCGeriatric #ACCFIT #ACCCVT
@accintouch.bsky.social @shummelmd.bsky.social @thornsberryjd.bsky.social

29.03.2025 23:22 β€” πŸ‘ 9    πŸ” 2    πŸ’¬ 1    πŸ“Œ 0
Post image Post image Post image

Join us for a fun #CardioObstetrics session at #ACC25 #CardioSky

πŸ“… Sun, Mar 30
⏰ 10AM

@accintouch.bsky.social @mdharringtonc.bsky.social @drklindley.bsky.social @abraguo.bsky.social @garimasharmamd.bsky.social @drmarthagulati.bsky.social @erinmichos.bsky.social @thornsberryjd.bsky.social

29.03.2025 23:10 β€” πŸ‘ 4    πŸ” 6    πŸ’¬ 1    πŸ“Œ 1
Post image Post image

Join us now for #ACC25 #CardioObstetrics Meet-Up
@accintouch.bsky.social @mdharringtonc.bsky.social @drklindley.bsky.social

29.03.2025 21:49 β€” πŸ‘ 6    πŸ” 3    πŸ’¬ 1    πŸ“Œ 0

Today at 4:30PM
Don’t miss #ACC25 #CardioObstetrics Meet-Up

29.03.2025 15:30 β€” πŸ‘ 8    πŸ” 4    πŸ’¬ 2    πŸ“Œ 0
Post image

πŸ“† Mark your calendars for Monday at #ACC25!

Wellstar MCG presents a high-stakes case: RotaWire entrapment, fracture, and retrievalβ€”titled β€œWhen It Rains It Pours.” β˜”οΈπŸ’™

You won’t want to miss this one!

#WellstarCVteam #CardioSky

@accintouch.bsky.social @jaccjournals.bsky.social

29.03.2025 23:01 β€” πŸ‘ 2    πŸ” 4    πŸ’¬ 0    πŸ“Œ 0
Post image

An oral formulation of semaglutide lowered the risk major adverse cardiovascular events by 14% in four years, with no change in safety profile compared to placebo, according to the SOUL study. #ACC25

Read the journal scan to learn more: bit.ly/3QTpizK

#CardioSky #MedSky

29.03.2025 22:01 β€” πŸ‘ 10    πŸ” 8    πŸ’¬ 0    πŸ“Œ 0
Post image

DAPA-TAVI: The #SGLT2 inhibitor dapagliflozin was superior to standard care alone in decreasing rates of all-cause mortality or worsening #HeartFailure in older adults w/ #vhdAS undergoing TAVI, resulting in a 28% relative risk β†˜οΈ. #ACC25

More: bit.ly/4cfLNsy

#cvSurg #CardioSky #MedSky

29.03.2025 22:22 β€” πŸ‘ 16    πŸ” 10    πŸ’¬ 1    πŸ“Œ 1
Post image

In SOUL, 2596/9650 (26.9%) participants were receiving SGLT2i at baseline (largest CVOT of combined GLP-1/SGLT2 to date)

The effect of oral semaglutide on cardiovascular outcomes was consistent, regardless of SGLT2i use

#ACC25

www.ahajournals.org/doi/abs/10.1...

29.03.2025 22:25 β€” πŸ‘ 8    πŸ” 6    πŸ’¬ 0    πŸ“Œ 0

I love this!

29.03.2025 21:26 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

#equity in heart care.
Yes. ❀️
#ACC25 #ACCCVT

29.03.2025 19:15 β€” πŸ‘ 3    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

@thornsberryjd is following 19 prominent accounts